Slide 1: Earnings Presentation Q3'25
EARNINGS PRESENTATION Q3’25
Slide 2: Agenda
AGENDA Q3’25 01 CONSOLIDATED FINANCIAL RESULTS 02 ESG UPDATE 03 RESULTS BY SEGMENT 04 OTHER FINANCIAL RESULTS 05 EXTRAORDINARY EVENT SUBSEQUENT
Slide 3: Consolidated Financial Results
01 CONSOLIDATED FINANCIAL RESULTS
Slide 4: Q3'25 Results – Consolidated
Q3’25 RESULTS – CONSOLIDATED Million Soles (S/ mm) Highlights Revenues +4.9% Mid-single digit growth in consolidated Revenues, with a moderate growth in our Food Retail segment and a slight growth in our Pharma 16,592 segment, despite a high comparison basis, and a decline in our 15,824 Shopping M
Slide 5: LTM Q3'25 – Consolidated Financial Results
LTM Q3’25 – CONSOLIDATED FINANCIAL RESULTS Food Shopping Pharma Retail Malls 1/ LTM Q3’25 (S/ mm; %) + + = Revenues 12,740 8,954 784 22,452 % Revenues Contribution 57% 40% 3% Adj. EBITDA2/ 1,134 1,524 426 2,954 % Adj. EBITDA Contribution 37% 49% 14% Adj. EBITDA Margin3/ 8.9% 17.0% 73.3% 13.2% _ Mark
Slide 6: ESG Update
02 ESG UPDATE InRetail
Slide 7: Q3'25 – ESG Update
Q3’25 – ESG UPDATE1/ Supermercados Peruanos +4 mm 157 ranked #2 among large Rations of “Formación Dual” participants companies and #3 nationwide food donated as of Q3’25 in Peru in the Aequales PAR Ranking S/383k +88k +S/17 mm Medicine donation with reverse logistics People Amount impacted per donat
Slide 8: Results by Segment
03 RESULTS BY SEGMENT InRetail
Slide 9: Q3'25 Results - Food Retail
Q3’25 RESULTS - FOOD RETAIL1/ Million Soles (S/ mm) S/ mm Q3'25 Q3'24 Var % Revenues 3,106 2,947 5.4% Gross Profit 728 702 3.7% 2/ 285 278 2.3% Adj. EBITDA Gross Mg 23.4% 23.8% - 39 bps 2/ 9.2% 9.5% - 28 bps Adj. EBITDA Mg Revenues grew 5.4%, despite the temporary closure of stores, with a SSS growt
Slide 10: Q3'25 Results - Pharma
Q3’25 RESULTS - PHARMA Million Soles (S/ mm) S/ mm Q3'25 Q3'24 Var % Revenues 2,314 2,295 0.8% Gross Profit 752 760 - 1.0% Adj. EBITDA 1/ 402 397 1.1% Gross Mg 32.5% 33.1% - 61 bps 1/ 17.4% 17.3% 5 bps Adj. EBITDA Mg Revenues increased 0.8%, driven by a positive growth in our Pharmacies2/ unit, with
Slide 11: Q3'25 Results - Shopping Malls
Q3’25 RESULTS - SHOPPING MALLS Million Soles (S/ mm) S/ mm Q3'25 Q3'24 Var % Revenues 187 197 - 5.0% Gross Profit 123 134 - 8.6% 1/ 109 125 - 12.8% Adj. EBITDA Gross Mg 65.6% 68.1% - 255 bps 2/ 78.6% 83.1% - 454 bps Net Rental Mg Revenues declined 5.0%, impacted by the temporary closure of the Real
Slide 12: Quarterly Openings and SSS by Segment
QUARTERLY OPENINGS AND SSS BY SEGMENT Openings Same Store Sales (SSS) Food Retail1/ Food Retail1/ 2024: 2.5% Sales Area (‘000 sqm) YTD3/: 3.0% 659 676 689 699 636 262 5.3% 202 221 239 251 4.2% 115 120 120 120 120 2.8% 3.3%3/ 1.5% 319 319 318 318 318 Q3’24 Q4’24 Q1’25 Q2’25 Q3’25 Q3’24 Q4’24 Q1’25 Q2
Slide 13: Other Financial Results
04 N° OTHER FINANCIAL [TÍTULO] RESULTS
Slide 14: Consolidated Net Income
CONSOLIDATED NET INCOME Million Soles (S/ mm) Net Income1/ Net Income Excluding FX and Mark-to-Market2/ -3.4% -20.6% 678 655 684 543 -12.7% -14.3% 276 241 252 216 Q3’24 Q3’25 YTD’24 YTD’25 Q3’24 Q3’25 YTD’24 YTD’25 Net Net Margin 5.1% 4.3% 4.3% 3.9% Margin 4.6% 3.8% 4.3% 3.3% Net Income Breakdown1/
Slide 15: Capex and Cash-Flow Breakdown
CAPEX AND CASH-FLOW BREAKDOWN Million Soles (S/ mm) Consolidated CAPEX 2024: S/1,041 mm YTD: S/745 mm 1,041 847 775 679 369 384 231 228 283 232 230 197 2019 2020 2021 20221/ 2023 Q1’24 Q2’24 Q3’24 Q4’24 Q1’25 Q2’25 Q3’25 Cash-Flow Breakdown -745 +223 -437 1,461 +1,643 1,454 -344 3332/ -2343/ 2682/ -
Slide 16: Consolidated Financial Debt
CONSOLIDATED FINANCIAL DEBT Million Soles (S/ mm) Consolidated Financial Debt1/ USD Exposure on Financial Debt Net Debt/Adj.EBITDA Debt/Adj.EBITDA Hedge USD PEN 2.6x 2.6x 2.4x 2.5x 2.5x 2.2x 2.1x 49% 51% 48% 50% 49% 2.1x 2.0x 1.9x 1% 2% 1% 0% 0% 50% 48% 51% 50% 51% LTM Q3’24 2024 LTM Q1’25 LTM Q2’25
Slide 17: Financial Debt by Segment
FINANCIAL DEBT BY SEGMENT1/ Million Soles (S/ mm) Net Debt/Adj. EBITDA Debt/Adj. EBITDA Total Consolidated Debt: S/7,314 mm Debt / Adj. EBITDA: 2.5x Net Debt / Adj. EBITDA: 2.0x Debt / Adj. EBITDA: 2.1x Net Debt / Adj. EBITDA: 1.6x 4.6x 4.1x 4.3x 4.0x 3.9x 2.9x 3.1x 1.7x 1.6x 2.8x 2.8x 1.6x 1.5x 1.5
Slide 18: Extraordinary Subsequent Event
05 EXTRAORDINARY SUBSEQUENT EVENT
Slide 19: Extraordinary Event Post Quarter
EXTRAORDINARY EVENT POST QUARTER Million Soles (S/ mm) Successful issuance of ~USD 500 mm InRetail Shopping Malls Senior Unsecured Notes Ratings Ba1/BB+/BBB- Tenor | Maturity 7 years Bullet | October 2032 Amount USD 375 million PEN 428 million Coupon 5.650% 7.125% Spread ~175bps ~170bps Issue price
Slide 20: Contact Information
CONTACT INFORMATION Andrea Fabbri Investor Relations Officer IR email: ir@inretail.pe This material was prepared solely for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any securities. This presentation may include forward-looking statements or state